FDA Approved: ORACEA — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved a supplemental NDA for ORACEA (doxycycline 40 mg) by Galderma Laboratories, L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• ORACEA (Doxycycline)

Snippet

SUPPL AP for ORACEA (DOXYCYCLINE)